View Older Stories View More Recent Stories

Jan 6, 2021 06:00AM Relay Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
Dec 14, 2020 06:20AM Relay Therapeutics (RLAY) Announces Worldwide License and Collaboration Agreement with Genentech for RLY-1971
Dec 14, 2020 06:00AM Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
Dec 14, 2020 06:00AM Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
Nov 12, 2020 04:05PM Relay Therapeutics Reports Third Quarter 2020 Financial Results
Nov 12, 2020 04:05PM Relay Therapeutics Reports Third Quarter 2020 Financial Results
Sep 3, 2020 04:05PM Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor
Sep 3, 2020 04:05PM Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor
Aug 27, 2020 06:50AM Relay Therapeutics Reports Second Quarter 2020 Financial Results
Aug 27, 2020 06:50AM Relay Therapeutics Reports Second Quarter 2020 Financial Results
View More Recent Stories View Older Stories